Williams Rowland Acquisition Corp arrants (11/12/2026) Stock (OTC: WRACW)

Williams Rowland Acquisition Corp arrants (11/12/2026) (OTC:WRACW) Stock, Quote.Headers.trade-ideas

Williams Rowland Acquisition Corp arrants (11/12/2026)

The Federal Bureau of Investigation is advising Americans to adopt encrypted messaging apps to <a target="_blank" href="https://www.benzinga.com/24/12/42333675/fbi-warns-of-ongoing-china-backed-telecom-hacks-heres-how-encrypted-messaging-could-be-your-last-line-of-defense" rel="noreferrer noopener">safeguard their communications</a>.
Gamers are spending more time watching gaming content than actually playing games. The study, conducted by Midia Research (via&nbsp;GamesIndustry.biz), reveals that gamers average 8.5 hours weekly watching game-related videos on platforms like YouTube and Twitch, <a target="_blank" href="https://benzinga.com/general/gaming/24/12/42305217/gamers-now-watch-more-than-they-play-how-publishers-can-reclaim-lost-revenue-report" rel="noreferrer noopener">compared to 7.4 hours actively gaming</a>.
Gaming
Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) announces Xbox Game Pass additions for December 2024, featuring Indiana Jones and the <a target="_blank" href="https://www.benzinga.com/general/gaming/24/12/42321564/indiana-jones-headlines-xbox-game-pass-december-2024-additions" rel="noreferrer noopener">Great Circle launching on Dec. 9</a>.
Microsoft‘s&nbsp;Activision is offering a limited-time opportunity for those who haven't yet jumped into Call of Duty: Black Ops 6 by announcing a seven-day free trial, <a target="_blank" href="https://www.benzinga.com/24/12/42353162/black-ops-6-free-trial-everything-you-can-play-from-dec-1320" rel="noreferrer noopener">starting next&nbsp;Friday, Dec. 13</a>.
In a recent&nbsp;interview&nbsp;with Japanese outlet Game Watch,&nbsp;Hidetaka Miyazaki,&nbsp;the studio's acclaimed creator, confirmed that Elden Ring 2 is <a target="_blank" href="https://www.benzinga.com/24/12/42297564/we-are-not-considering-elden-ring-2-says-fromsoftwares-miyazaki" rel="noreferrer noopener">not part of the company's plans</a>.
Sony Group Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) introduced controller-free hand tracking for PS VR2 at Siggraph Asia 2024, demoing <a target="_blank" href="https://www.benzinga.com/24/12/42325278/ps-vr2-gets-controller-free-hand-tracking-feature" rel="noreferrer noopener">it with a cleaning mini-game</a>.
Retail/Media
Walt Disney Co.&#8217;s&nbsp;Disney+&nbsp;announced its expansion in sports content via <a target="_blank" href="https://www.benzinga.com/general/entertainment/24/12/42330923/espn-lands-on-disney-in-major-content-fusion-heres-what-it-actually-means" rel="noreferrer noopener">the integration of&nbsp;</a><a target="_blank" href="https://www.benzinga.com/general/entertainment/24/12/42330923/espn-lands-on-disney-in-major-content-fusion-heres-what-it-actually-means" rel="noreferrer noopener">ESPN</a><a target="_blank" href="https://www.benzinga.com/general/entertainment/24/12/42330923/espn-lands-on-disney-in-major-content-fusion-heres-what-it-actually-means" rel="noreferrer noopener">&nbsp;into its platform</a>.
Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) unveiled advanced AI chip&nbsp;clusters designed to enhance the <a target="_blank" href="https://www.benzinga.com/24/12/42309656/amazon-unleashes-powerful-ai-chip-clusters-to-supercharge-anthropics-models-while-challenging-nvidia-and-openais-dominance" rel="noreferrer noopener">performance of its partner,&nbsp;</a><a target="_blank" href="https://www.benzinga.com/24/12/42309656/amazon-unleashes-powerful-ai-chip-clusters-to-supercharge-anthropics-models-while-challenging-nvidia-and-openais-dominance" rel="noreferrer noopener">Anthropic</a>.
Amazon.com&nbsp;co-founder&nbsp;Jeff Bezos&nbsp;shared his positive outlook on&nbsp;Donald Trump's&nbsp;upcoming second term, <a target="_blank" href="https://www.benzinga.com/media/24/12/42331420/jeff-bezos-optimistic-about-trumps-second-term-wants-to-help-streamline-rules-we-do-have-too-many-regulations-in-this-country" rel="noreferrer noopener">underscoring potential regulatory reductions</a>.&nbsp;
Smartphone
Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) is facing a legal challenge from one of its own, as an ad tech manager has accused the company of violating employee <a target="_blank" href="https://www.benzinga.com/news/legal/24/12/42283614/apple-faces-lawsuit-over-alleged-snooping-on-employees-iphones-and-other-devices" rel="noreferrer noopener">privacy rights through its policies</a>.
Apple reported it plans to launch a foldable iPhone in 2026. It could breathe new life into the foldable smartphone market, which has been <a href="https://www.benzinga.com/markets/24/12/42286671/apples-foldable-iphone-could-spark-smartphone-market-revival-in-2026-says-expert" target="_blank" rel="noreferrer noopener">experiencing waning consumer interest</a>.
Apple&nbsp;is reportedly facing a delay in its ambitious smart home vision, with a key product now<a target="_blank" href="https://www.benzinga.com/24/12/42308843/apples-bold-smart-home-vision-could-be-delayed-until-2025-as-top-analyst-predicts-display-equipped-homepod-will-reposition-product-line-just-like-apple-watch" rel="noreferrer noopener"> expected to launch in 2025</a>.
Technology
Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) CEO&nbsp;Mark Zuckerberg&nbsp;is seeking to play an "active role" in shaping technology policies under the administration<a target="_blank" href="https://www.benzinga.com/24/12/42306998/zuckerberg-seeks-active-role-in-trumps-tech-policies-says-metas-president-of-global-affairs-while-admitting-they-overdid-it-a-bit-during-pandemic-content-crackdown" rel="noreferrer noopener"> of President-elect&nbsp;</a><a target="_blank" href="https://www.benzinga.com/24/12/42306998/zuckerberg-seeks-active-role-in-trumps-tech-policies-says-metas-president-of-global-affairs-while-admitting-they-overdid-it-a-bit-during-pandemic-content-crackdown" rel="noreferrer noopener">Donald Trump</a>.
China's&nbsp;BYD Co., Ltd. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDF#OTC">BYDDF</a>) has quietly become a major force in&nbsp;Apple manufacturing ecosystem, now assembling more than 30% of iPads while planning an ambitious artificial <a target="_blank" href="https://www.benzinga.com/news/global/24/12/42260943/tesla-rival-byd-assembles-over-30-of-ipads-for-apple-and-plans-ai-robots-for-nvidia-how-warren-buffett-backed-firm-is-supporting-tim-cook-led-tech-empire" rel="noreferrer noopener">intelligence venture with&nbsp;</a><a target="_blank" href="https://www.benzinga.com/news/global/24/12/42260943/tesla-rival-byd-assembles-over-30-of-ipads-for-apple-and-plans-ai-robots-for-nvidia-how-warren-buffett-backed-firm-is-supporting-tim-cook-led-tech-empire" rel="noreferrer noopener">Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).</a>
Read: <a target="_blank" href="https://www.benzinga.com/24/12/42260222/how-nvidia-ceos-clever-but-nerdy-pick-up-line-turned-a-homework-proposal-into-marriage-while-building-338-trillion-ai-chip-giant-along-the-way" rel="noreferrer noopener">How Nvidia CEO Jensen Huang&#8217;s Clever Pick-Up Line Turned A Homework Proposal Into Marriage While Building $3.38 Trillion AI Chip Giant Along The Way</a>
Alphabet Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) Google&nbsp;introduced its&nbsp;Veo&nbsp;video generator to select Cloud customers. &nbsp;The AI model, capable of creating short video clips from images and prompts, is now available in private preview on&nbsp;<a target="_blank" href="https://www.benzinga.com/24/12/42307366/googles-veo-video-generator-arrives-on-cloud-how-quora-and-mondelez-are-using-ai-for-creative-content" rel="noreferrer noopener">Vertex AI</a><a target="_blank" href="https://www.benzinga.com/24/12/42307366/googles-veo-video-generator-arrives-on-cloud-how-quora-and-mondelez-are-using-ai-for-creative-content" rel="noreferrer noopener">, Google's AI development platform</a>.
Elon Musk&#8217;s SpaceX has completed its first&nbsp;Starlink&nbsp;satellite constellation&nbsp;aimed at direct-to-cell phone connectivity, <a target="_blank" href="https://www.benzinga.com/general/space/24/12/42333605/elon-musks-spacex-completes-first-starlink-satellite-constellation-for-cell-phones" rel="noreferrer noopener">making the service fully operational</a>.
Artificial Intelligence (AI)
ChatGPT-parent&nbsp;OpenAI&nbsp;is setting a target to&nbsp;reach 1 billion users&nbsp;by 2025, driven by new AI products, a key partnership with&nbsp;Apple, and <a target="_blank" href="https://www.benzinga.com/media/24/12/42259023/apple-partnership-ai-agents-and-major-infrastructure-investments-openai-executives-outline-strategy-to-attract-1b-users-by-2025" rel="noreferrer noopener">significant infrastructure investments</a>.
OpenAI&nbsp;CEO&nbsp;Sam Altman&nbsp;announced a special event <a target="_blank" href="https://www.benzinga.com/tech/24/12/42332451/sam-altman-teases-12-days-of-openai-christmas-magic-users-predict-unveiling-of-sora-o1-reasoning-model-and-more" rel="noreferrer noopener">titled "12 Days of OpenAI."</a>
Read: <a target="_blank" href="https://www.benzinga.com/24/12/42256614/trumps-ai-czar-plans-alibabas-new-model-cathie-wood-on-tesla-ai-and-musks-combat-transformation-this-week-in-artificial-intelligence" rel="noreferrer noopener">Trump&#8217;s AI Czar Plans, Alibaba&#8217;s New Model, Cathie Wood On Tesla AI, And Musk&#8217;s Combat Transformation: This Week In Artificial Intelligence</a>
OpenAI&nbsp;CEO&nbsp;Sam Altman&nbsp;has downplayed concerns about former friend and now rival&nbsp;Elon Musk&#8217;s&nbsp;political ties with President-elect&nbsp;Donald Trump&nbsp;but acknowledged <a target="_blank" href="https://www.benzinga.com/24/12/42334927/sam-altman-brushes-off-elon-musks-trump-ties-but-admits-xai-is-a-serious-threat-to-openai-i-may-turn-out-to-be-wrong-but" rel="noreferrer noopener">that xAI is a formidable competitor</a>.
Read: <a target="_blank" href="https://www.benzinga.com/24/12/42259228/are-large-language-models-digital-gods-or-mere-imitators-tesla-advocate-pierre-ferragu-shares-his-thoughts" rel="noreferrer noopener">Are ChatGPT Like LLMS &#8216;Digital Gods&#8217; Or Just &#8216;Imitating Monkeys&#8217; — Investor In Elon Musk&#8217;s Grok Shares His Thoughts</a>
Misinformation expert&nbsp;Jeff Hancock&nbsp;confessed to utilizing&nbsp;OpenAI&#8217;s ChatGPT&nbsp;for organizing citations in a legal document, with hallucinations calling into <a target="_blank" href="https://www.benzinga.com/tech/24/12/42336438/misinformation-expert-admits-using-chatgpt-to-file-affidavit-on-misinformation-says-openais-chatbot-added-the-fake-details" rel="noreferrer noopener">question the integrity of the filing itself</a>.

News

Tech

AAPL

AMZN

BYDDF

GOOG

MSFT

NVDA

Sony Group Corporation American Depositary Shares

SONY

Consumer Tech News (Dec 2-Dec 6): FBI Advises To Adopt Encrypted Messaging Apps, Elon Musk Completed First Starlink Satellite Constellation & More

President-elect Donald Trump weighed in on the fall of Syrian dictator Bashar Assad after a rebel group seized control of Damascus, ending five decades of Assad family rule.
What Happened: On Sunday, Trump shared his reaction to Assad&#8217;s exit from Syria after 24 years in power on his social media platform, Truth Social. 
&#8220;Assad is gone. He has&nbsp;fled his country,&#8221; Trump said in the <a href="https://truthsocial.com/@realDonaldTrump/posts/113615912452824634">post</a>.
&#8220;His protector, Russia, Russia, Russia, led by Vladimir Putin, was not interested in protecting him any longer. There was no reason for Russia to be there in the first place,&#8221; Trump wrote. &#8220;They lost all interest in Syria because of Ukraine, where close to 600,000 Russian soldiers lay wounded or dead, in a war that should never have started, and could go on forever.&#8221;
Trump also commented on the weakened state of both Russia and Iran, attributing it to the Ukraine conflict and Israel&#8217;s military success, respectively. He called for an immediate ceasefire and the commencement of negotiations.
Also Read: <a href="https://www.benzinga.com/news/24/10/41196317/trump-urges-israel-to-target-iran-nuke-sites-hit-nuclear-first-and-worry-about-the-rest-later">Trump Urges Israel To Target Iran Nuke Sites: &#8216;Hit Nuclear First And Worry About The Rest Later&#8217;</a>
&#8220;Russia and Iran are in a weakened state right now, one because of Ukraine and a bad economy, the other because of Israel and its fighting success,&#8221; Trump continued. &#8220;Likewise, Zelenskyy and Ukraine would like to make a deal and stop the madness. They have ridiculously lost 400,000 soldiers, and many more civilians. There should be an immediate ceasefire and negotiations should begin.&#8221;
Assad, notorious for using chemical weapons on his own people, fled with his family, as per Syrian television reports. The destination of the fleeing family remains undisclosed.
Following Assad&#8217;s departure, Syrians gathered in&nbsp;central squares of Damascus to&nbsp;celebrate.&nbsp;Syria has been embroiled in&nbsp;a&nbsp;nearly 14-year civil war as&nbsp;Islamist rebels sought to overthrow&nbsp;Assad and terminate the Assad family&#8217;s&nbsp;rule over the Syrian Arabian&nbsp;Republic.
Why It Matters: The departure of Bashar Assad marks a significant turning point in the Syrian conflict. Assad&#8217;s rule has been characterized by brutal repression and the use of chemical weapons against his own people. His exit could pave the way for a potential political transition in Syria, although the future remains uncertain.
Trump&#8217;s comments reflect the international community&#8217;s concern over the ongoing conflicts in Syria and Ukraine. With Russia&#8217;s involvement in both conflicts, the geopolitical landscape is increasingly complex. 
The call for a ceasefire and negotiations underscores the urgency of resolving these conflicts and restoring stability in the region.
Read Next
<a href="https://www.benzinga.com/news/24/11/42154695/mary-trump-says-her-uncle-donald-is-putins-puppet">Mary Trump Says Her Uncle Donald Is &#8216;Putin&#8217;s Puppet&#8217;</a>
Image: Wikimedia Commons

Politics

Global

Trump on Assad's Fall: Putin 'Was Not Interested In Protecting Him Any Longer'

These eleven large-cap stocks were the worst performers in the last week. Are they in your portfolio?
<ol>
<li>Texas Pacific Land Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPL#NYSE">TPL</a>) stock tumbled 16.35%, probably due to OPEC's supply decision.</li>
<li>Microchip Technology Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) shares plummeted 13.03% after the company announced it halted its application for U.S. semiconductor government grants and cut revenue guidance <a href="https://www.benzinga.com//node/42344223" target="_blank" rel="noreferrer noopener">for the December 2024 quarter</a>.</li>
<li>Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) shares dived 13.01% after the company announced <a href="https://www.benzinga.com//node/42267115" target="_blank" rel="noreferrer noopener">the retirement of CEO Pat Gelsinger</a>.</li>
<li>KB Financial Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KB#NYSE">KB</a>) stock declined 12.68%.</li>
<li>Guidewire Software, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) stock dipped 12.48% after it <a href="https://www.benzinga.com//node/42351588" target="_blank" rel="noreferrer noopener">reported first-quarter results</a>. Analysts revised their <a href="https://www.benzinga.com/quote/gwre/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecast on the stock</a>.</li>
<li>Toast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>) stock fell 10.86%. It expanded its partnership with Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) to give restaurants more choices and provide guests <a href="https://www.benzinga.com//node/42347476" target="_blank" rel="noreferrer noopener">additional delivery options</a>. Several analysts <a href="https://www.benzinga.com//node/42268538" target="_blank" rel="noreferrer noopener">downgraded the stock</a>.</li>
<li>UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) stock declined 9.93% following the fatal shooting of the insurance division's CEO Brian Thompson outside a Manhattan hotel where the company was <a href="https://www.benzinga.com//node/42365853" target="_blank" rel="noreferrer noopener">hosting its annual investor conference</a>.</li>
<li>Old Dominion Freight Line, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODFL#NASDAQ">ODFL</a>) stock fell 9.83% last week <a href="https://www.benzinga.com//node/42300450" target="_blank" rel="noreferrer noopener">due to the threat of new tariffs</a> on Canada, which could impact several sectors, including transportation companies.</li>
<li>Halliburton Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>) stock lost 9.67% last week due to ongoing conflict in the Middle East affecting commodity prices.</li>
<li>POSCO HOLDINGS INC. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKX#NYSE">PKX</a>) shares decreased 9.67%, probably after South Korean President Yoon <a href="https://www.benzinga.com//node/42306717" target="_blank" rel="noreferrer noopener">Suk Yeol declared martial law</a>.</li>
<li>Rocket Lab USA, Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) stock dipped 9.53% last week due to profit-taking in the sector. The company also stated it would announce the launch <a href="https://www.benzinga.com//node/42351319" target="_blank" rel="noreferrer noopener">window for its sixth synspective mission on December 18</a>.</li>
</ol>
Image via Shutterstock

Large Cap

Movers

Trading Ideas

GWRE

INTC

MCHP

ODFL

RKLB

TOST

UBER

Intel, UnitedHealth And Rocket Lab Are Among Top 11 Large Cap Losers Last Week (Dec 2-Dec 6): Are The Others In Your Portfolio?

The week was a whirlwind of activity in the AI sector, with major players making significant strides. From Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) unveiling an AI model that outperforms its rivals, to Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) redefining AI data centers, and Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) shifting its focus in the AI chip wars, the AI landscape is rapidly evolving. Let&#8217;s dive into the top stories.
Meta&#8217;s Llama 3.3 70B Outperforms Google, OpenAI, and Amazon&#8217;s AI Models
Meta has launched Llama 3.3 70B, a new AI model that surpasses competitors like Google, OpenAI, and Amazon in performance. Announced on Friday, the model offers the performance of Meta's largest Llama model, Llama 3.1 405B, but at a reduced cost. Ahmad Al-Dahle, Meta's VP of generative AI, highlighted that Llama 3.3 70B leverages advanced post-training techniques for efficient core performance enhancement.
<a href="https://www.benzinga.com/24/12/42376972/metas-llama-33-70b-the-new-ai-model-that-outperforms-google-openai-and-amazon-with-unmatched-efficiency">Read the full article here.</a>
Nvidia&#8217;s Liquid-Cooled Blackwell GPUs Revolutionize AI Data Centers
Nvidia is transforming the AI infrastructure with its Blackwell GPUs, prompting a significant shift towards liquid cooling in data centers. With cooling challenges resolved, Nvidia plans to increase production of liquid-cooled GB200 server racks in Q1 2025, marking a crucial moment for the AI server ecosystem.
<a href="https://www.benzinga.com/24/12/42269031/nvidias-blackwell-liquid-cooling-revolution-fuels-ai-growth">Read the full article here.</a>
See Also: <a href="https://www.benzinga.com/media/24/12/42331420/jeff-bezos-optimistic-about-trumps-second-term-wants-to-help-streamline-rules-we-do-have-too-many-regulations-in-this-country?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Jeff Bezos Optimistic About Trump&#8217;s Second Term, Wants To Help Streamline Rules</a>
Amazon Shifts Focus in AI Chip Wars
Amazon has decided to halt the development of its Inferentia AI chip, shifting its focus to the Trainium chip. This decision is part of Amazon's broader strategy to enhance cost performance in AI model training. Since its entry into the AI chip market in 2018, Amazon Web Services has been offering both Inferentia and Trainium chips to AI companies.
<a href="https://www.benzinga.com/media/24/12/42356920/amazon-halts-inferentia-ai-chip-development-to-take-on-nvidia-how-trainium-is-shaping-up-to-be-the-new-weapon-in-ai-chip-wars">Read the full article here.</a>
Google CEO Sundar Pichai Fires Back At Microsoft Over AI
Alphabet Inc.&#8217;s CEO Sundar Pichai dismissed criticism of his company&#8217;s AI strategy while targeting Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>). During his appearance at The New York Times&#8217; DealBook Summit Pichai responded to Microsoft CEO Satya Nadella's criticism, suggesting a direct comparison between their companies' AI models. Pichai noted that Microsoft relies on ChatGPT-parent OpenAI technology for its models.
<a href="https://www.benzinga.com/24/12/42359072/sundar-pichai-takes-a-jab-at-microsofts-ai-efforts-theyre-using-someone-elses-models-doubling-down-on-googles-innovation-power">Read the full article here.</a>
Elon Musk&#8217;s xAI Raises $6B For The 2nd Time This Year
Elon Musk-led artificial intelligence (AI) startup xAI disclosed that it has raised $6 billion, with nearly 97 investors participating in the fundraising round. xAI&#8217;s latest fundraise comes as the AI startup is looking to expand the footprint of its Colossus supercomputer tenfold.
<a href="https://www.benzinga.com/tech/24/12/42358400/elon-musks-xai-raises-6b-for-the-2nd-time-this-year-as-it-looks-to-take-the-challenge-to-openai-google-and-jeff-bezos-backed-anthropic">Read the full article here.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42309656/amazon-unleashes-powerful-ai-chip-clusters-to-supercharge-anthropics-models-while-challenging-nvidia-and-openais-dominance?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Jeff Bezos&#8217; Amazon Unveils Powerful AI Chip Clusters To Supercharge Anthropic&#8217;s Models</a></li>
</ul>
Photo courtesy: Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/Rounak-Jain" target="_blank" rel="noreferrer noopener">Rounak Jain</a>

Meta's Llama 3.3 70B Outshines Rivals, Nvidia's Liquid-Cooling Breakthrough, xAI Raises $6B: This Week In AI

Crypto giant Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) surged beyond the $100,000 mark last week, reaching an all-time high of $103,259. This significant increase is largely credited to the perceived pro-crypto stance of <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40429919/trumps-crypto-reversal-ex-president-reportedly-holds-more-than-1m-in-digital-assets">President-elect Donald Trump.</a>
What Happened: Bitcoin&#8217;s value has seen a nearly 50% increase since November 5, following the election of Trump. The incoming administration is anticipated to be the first to openly endorse cryptocurrencies.
The pro-crypto stance of Trump&#8217;s administration has wider implications for investors, the dollar, taxes, federal regulation, Treasury bonds, and gold, <a href="https://www.barrons.com/amp/articles/trump-bitcoin-crypto-ether-052688ed">reports</a> Barron&#8217;s.
The President-elect has made commitments to the crypto industry, including the establishment of a &#8220;strategic national Bitcoin stockpile&#8221; and the appointment of a crypto advisory council.
As per Benzinga data, the crypto ecosystem&#8217;s market cap is now at $3.6 trillion, with Bitcoin contributing over 55%. This signifies a 124% increase year to date and a staggering 1,720% increase&nbsp;over the past five years.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/40001426/trump-aims-to-make-us-crypto-capital-of-the-planet-well-get-it-done">Trump Aims To Make US &#8216;Crypto Capital Of The Planet&#8217;: &#8216;We&#8217;ll Get It Done&#8217;</a>
Trump&#8217;s administration, including Trump himself, has strong connections to crypto. Trump has&nbsp;owned crypto, including at least&nbsp;$1 million in Ether (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), and his business ventures include a crypto payment service named TruthFi.
With the expected crypto-friendly environment under the Trump administration, companies are preparing for new initiatives. Goldman Sachs is considering spinning&nbsp;out its digital asset platform,&nbsp;and BlackRock intends&nbsp;to expand its tokenized money-market&nbsp;fund.
Michael Saylor, Chairman of MicroStrategy, a crypto holding company, expressed, &#8220;You've&nbsp;got a promise from the&nbsp;Trump administration to end the&nbsp;war on crypto, to make&nbsp;Bitcoin great.&#8221; This shift from litigation to support is viewed as a pivotal change for digital assets.
Why It Matters: The pro-crypto stance of the incoming administration is a significant departure from previous administrations. This shift is expected to provide a more favorable environment for cryptocurrencies, potentially leading to increased adoption and investment. 
The impact of this change is already being felt, with Bitcoin&#8217;s value skyrocketing and companies preparing to launch new crypto initiatives. 
The long-term implications of this shift could be transformative for the financial industry.
Read Next
<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42024635/scaramucci-trumps-crypto-support-could-push-bitcoin-to-150k">Scaramucci: Trump&#8217;s Crypto Support Could Push Bitcoin To $150K</a>
This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Image: Midjourney

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$BTC

$ETH

Trump Fuels Bitcoin Rally, But Where Will It Go Next Year?

These eleven large-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>Credo Technology Group Holding Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) shares jumped 51.61% after the company reported second-quarter results, and multiple firms raised their <a href="https://www.benzinga.com//node/42298407" target="_blank" rel="noreferrer noopener">price forecast on the stock</a>.</li>
<li>Super Micro Computer Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) stock escalated 34.59% last week. An internal investigation led by its Special Committee found "no evidence of misconduct or fraud" <a href="https://www.benzinga.com//node/42367077" target="_blank" rel="noreferrer noopener">involving management or the board</a>.</li>
<li>DocuSign, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) shares rose 34.26% after the company reported third-quarter results and <a href="https://www.benzinga.com//node/42352653" target="_blank" rel="noreferrer noopener">issued better-than-expected guidance</a>. Several analysts raised <a href="https://www.benzinga.com/quote/docu/analyst-ratings" target="_blank" rel="noreferrer noopener">their price forecasts for the stock</a>.</li>
<li>Rubrik, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) stock rocketed 27.17% after reporting <a href="https://www.benzinga.com//node/42353379" target="_blank" rel="noreferrer noopener">better-than-expected third-quarter results</a>. Several analysts <a href="https://www.benzinga.com/quote/rbrk/analyst-ratings" target="_blank" rel="noreferrer noopener">raised the price forecast on the stock</a>.</li>
<li>Lululemon Athletica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) climbed 24.62% after reporting better-than-expected third-quarter earnings, and <a href="https://www.benzinga.com//node/42367217" target="_blank" rel="noreferrer noopener">analysts boosted the price forecast</a> on the stock.</li>
<li>Pure Storage, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSTG#NYSE">PSTG</a>) stock grew 22.51% after the company reported better-than-expected third-quarter financial results and <a href="https://www.benzinga.com//node/42303442" target="_blank" rel="noreferrer noopener">fourth-quarter guidance</a>. Several analysts raised <a href="https://www.benzinga.com/quote/pstg/analyst-ratings" target="_blank" rel="noreferrer noopener">the price forecast on the stock</a>.</li>
<li>Marvell Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) shares surged 22.46%  after the company reported upbeat earnings for the third quarter and<a href="https://www.benzinga.com//node/42321281" target="_blank" rel="noreferrer noopener"> analysts boosted the price forecast</a>.</li>
<li>Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) stock rose 21.86% last week on analyst commentary from Needham, which maintained a "Buy" rating and <a href="https://www.benzinga.com//node/42325582" target="_blank" rel="noreferrer noopener">reiterated the $100 price target</a>.</li>
<li>Aurora Innovation, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>) stock upped 21.33% last week.</li>
<li>American Airlines Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) shares increased 19.83% after it reported better-than-expected fourth <a href="https://www.benzinga.com//node/42345395" target="_blank" rel="noreferrer noopener">quarter and full-year outlook</a>.</li>
<li>Applovin Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) stock jumped 19.23% after <a href="https://www.benzinga.com//node/42324175" target="_blank" rel="noreferrer noopener">some analysts</a> boosted <a href="https://www.benzinga.com/quote/app/analyst-ratings" target="_blank" rel="noreferrer noopener">the price forecast</a>.</li>
</ol>
Photo via Shutterstock

CRDO

DOCU

LULU

MRVL

PSTG

RBRK

ROKU

SMCI

Super Micro Computer, lululemon And Roku Are Among Top 11 Large Cap Gainers Last Week (Dec 2-Dec 6): Are The Others In Your Portfolio?

The past week was a rollercoaster ride in the cryptocurrency market. From XRP&#8217;s explosive gain to Shiba Inu&#8217;s burning spree, the crypto world was buzzing with activity. Let&#8217;s dive into the top stories that shaped the crypto market over the weekend.
XRP&#8217;s Parabolic Uptrend
Over the last weekend, XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) witnessed a significant rise. The uptrend was fueled by new ETF applications and increased whale activity. Noted investor Raoul Pal highlighted XRP&#8217;s &#8220;great-looking&#8221; chart, drawing parallels with a previous long wedge pattern that led to a whopping 5,600% rally. Pal coined the current phase as &#8220;Banana Zone Part 1.&#8221;
<a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42271334/xrp-price-explodes-for-447-gain-why-is-xrp-going-up-again">Read the full article here.</a>
Shiba Inu Burns 53 Million Coins
Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) made headlines as it burned 53 million coins in a single day. The coin&#8217;s burn rate and a steady increase in whale transactions have contributed to its recent momentum. Traders are optimistic about SHIB&#8217;s trajectory, with Bluntz Capital tweeting about a potential major price spike for Shiba Inu.
<a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42361326/dogecoin-killer-shiba-inu-burns-53-million-coins-in-a-day-what-is-going-on-with-shib">Read the full article here.</a>
Fed Chair Powell on Bitcoin
Federal Reserve Chair Jerome Powell addressed Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) at the DealBook Summit, likening the cryptocurrency to gold. Powell dismissed the idea that Bitcoin undermines the Federal Reserve or the strength of the U.S. dollar, emphasizing that Bitcoin is not being used as a primary form of payment or a reliable store of value due to its high volatility.
<a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42325788/fed-chair-powell-bitcoin-is-like-gold-just-virtual-and-digital">Read the full article here.</a>
Congressman Buys Meme Coins
Rep. Mike Collins (R-Ga.) disclosed buying two cryptocurrencies, including the meme coin Ski Mask Dog. The Congressman purchased between $2,000 to $30,000 worth of the meme coin, sparking interest among investors who closely follow the trading activities of Congress members. Collins also bought Aerodrome, a cryptocurrency he purchased before.
<a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42330146/congressman-buys-meme-coins-ski-mask-dog-coin-climbs-in-value-after-disclosure-i-liked-the-coins-so-i-bought-them">Read the full article here.</a>
NYC Mayor&#8217;s Bitcoin Victory Lap
New York City Mayor Eric Adams had the last laugh earlier this week as Bitcoin&#8217;s value edges closer to the $100,000 mark. Adams, who took his first three paychecks in Bitcoin and Ethereum ETH/USD, addressed his skeptics at a press conference, reminding them of their initial ridicule.
<a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42323060/nyc-mayor-eric-adams-takes-victory-lap-remember-yall-laughed-when-i-first-got-my-bitcoin-whos-laughing-now">Read the full article here.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42323060/nyc-mayor-eric-adams-takes-victory-lap-remember-yall-laughed-when-i-first-got-my-bitcoin-whos-laughing-now?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">NYC Mayor Eric Adams Takes Victory Lap: &#8216;Remember Y&#8217;All Laughed When I First Got My Bitcoin? Who&#8217;s Laughing Now?&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock
 This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/anan-ashraf" target="_blank" rel="noopener">Anan Ashraf.</a>

$SHIB

$XRP

XRP's Parabolic Uptrend, Congressman Buys Meme Coins, Fed Chair Powell Likens Bitcoin To Gold And More: This Week In Crypto

The weekend was abuzz with news from the tech giant Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>). From the development of in-house modems to the anticipated launch of a foldable iPhone, the company has been making waves in the tech industry. Here&#8217;s a quick round-up of the top stories that unfolded over the weekend.
Apple&#8217;s In-House Modem Development
Apple is reportedly developing its own modem technology, internally named Sinope. This move could result in slimmer iPhones and introduce cellular capabilities to Macs and headsets like Vision Pro. The new modem is set to debut next year and will gradually replace components from Qualcomm Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) over three years.
<a href="https://www.benzinga.com/24/12/42376583/how-apples-billion-dollar-modem-gamble-could-redefine-the-future-of-macs-headsets-and-foldable-iphones-report">Read the full article here.</a>
Revival of the Smartphone Market with Foldable iPhone
Apple&#8217;s reported plans to launch a foldable iPhone in 2026 could breathe new life into the foldable smartphone market, which has been experiencing waning consumer interest. Display analyst Ross Young anticipates a growth of over 30% in the foldable market in 2026.
<a href="https://www.benzinga.com/markets/24/12/42286671/apples-foldable-iphone-could-spark-smartphone-market-revival-in-2026-says-expert">Read the full article here.</a>
See Also: <a href="https://www.benzinga.com/tech/24/12/42312508/tesla-ceo-elon-musk-agrees-with-apple-co-founder-steve-jobs-on-guiding-talent-you-know-who-the-best-managers-are?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla CEO Elon Musk Agrees With Apple Co-Founder Steve Jobs On Guiding Talent</a>
Tim Cook on Apple&#8217;s Future and His Retirement Plans
Apple CEO Tim Cook shared insights on the company's future, touching on the iPhone 16's new camera button, Vision Pro sales, and AirPods' evolution. Cook also discussed the decision to add a physical button to the iPhone 16 for camera control, a departure from Steve Jobs&#8217; aversion to buttons.
<a href="https://www.benzinga.com/24/12/42356192/tim-cook-breaks-silence-on-defying-steve-jobs-design-philosophy-with-the-iphone-16s-camera-button-vision-pro-sales-airpods-disrupting-hearing-aids-and-whether-hell-lead-apple-into-the-next-era">Read the full article here.</a>
Apple Stock Hits New High Despite Sales Slowdown
Despite a general market slowdown, Apple&#8217;s stock soared to a new 52-week high on Tuesday, closing at $242.65. This comes at a time when reports have pointed to iPhone sales lagging amid a lukewarm reception to new AI features.
<a href="https://www.benzinga.com/24/12/42310095/apple-shares-hit-new-high-despite-iphone-sales-slowdown-expert-reiterates-that-street-is-starting-to-realize-iphone-16-is-the-start-of-a-super-cycle">Read the full article here.</a>
Most Popular Free iPhone Apps in America
The latest rankings of the most popular free apps on Apple&#8217;s iPhone in the U.S. reveal a strong inclination toward games, social media platforms, and productivity tools. Leading the pack is Block Blast, a puzzle game developed by Artemis Limited.
<a href="https://www.benzinga.com/24/12/42261260/the-hottest-free-iphone-apps-in-america-right-now-block-blast-threads-and-chatgpt-lead-the-pack">Read the full article here.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/media/24/12/42331420/jeff-bezos-optimistic-about-trumps-second-term-wants-to-help-streamline-rules-we-do-have-too-many-regulations-in-this-country?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Jeff Bezos Optimistic About Trump&#8217;s Second Term, Wants To Help Streamline Rules</a></li>
</ul>
Photo courtesy: Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/Rounak-Jain" target="_blank" rel="noreferrer noopener">Rounak Jain</a>

QCOM

Apple's In-House Modems, Foldable iPhones, And Tim Cook On Cupertino's Future: This Week In Appleverse

The past week has been a whirlwind of economic insights and policy debates. From&nbsp;Jeff Bezos&nbsp;challenging&nbsp;Elon Musk&#8216;s cost-cutting strategies to&nbsp;Donald Trump&#8216;s tariff plans stirring up potential trade wars, the financial world is buzzing. Meanwhile, the&nbsp;Federal Reserve hints at a possible rate cut, and the U.S. job market shows unexpected strength.
Let&#8217;s dive into the key stories that shaped the weekend.
Bezos Advocates for Growth Over Cuts
At the New York Times DealBook Summit,&nbsp;Amazon.com Inc. founder Bezos emphasized the importance of economic growth in tackling national debt. He suggested that the U.S. should aim for a GDP growth rate of 3-5% annually, rather than focusing solely on reducing debt. Bezos stated, &#8220;We need a growth orientation in this country. This is the most important thing… a growth mindset.&#8221;&nbsp;
<a href="https://www.benzinga.com/news/24/12/42335531/jeff-bezos-counters-elon-musk-led-doge-cost-cutting-plan-says-america-needs-growth-orientation-heres-what-the-amazon-founder-said-to-tackle-national-debt">Read the full article here.</a>
Trump&#8217;s Tariff Threats and BRICS
President-elect Donald Trump&#8217;s proposal to impose 100% tariffs on BRICS nations has sparked concerns of a potential trade war.&nbsp;Milken Institute&nbsp;Chief Economist William Lee noted that Trump&#8217;s strategy reflects his preference for direct negotiations over multilateral agreements. Lee highlighted that these tariff threats are intended to leverage negotiations with major trading partners.
<a href="https://www.benzinga.com/news/global/24/12/42259898/economist-warns-trump-that-brics-will-act-collectively-and-spark-a-trade-war-with-us-over-100-tariff-threats">Read the full article here.</a>
See Also:&nbsp;<a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42346164/november-jobs-report-preview-will-it-seal-the-deal-for-a-fed-interest-rate-cut?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">November Jobs Report Preview: Will It Seal The Deal For A Fed Interest Rate Cut?</a>
Goldman Sachs Warns Of Economic Risks
Goldman Sachs&nbsp;has raised alarms over Trump&#8217;s aggressive tariff plan, which includes a 25% tariff on imports from Canada and Mexico. The firm predicts significant economic repercussions, including a potential 4% GDP contraction for Canada and Mexico, and a 0.4% shrinkage for the U.S. economy. Economists at Goldman Sachs caution that such tariffs could lead to increased consumer prices and slower growth.
<a href="https://www.benzinga.com/24/12/42291861/trumps-tariff-plan-risks-economic-pain-for-north-america-goldman-sachs-warns">Read the full article here.</a>
Federal Reserve&#8217;s Rate Cut Consideration
Christopher Waller, member of the Federal Reserve Board of Governors, has indicated a potential interest rate cut at the upcoming December meeting. Speaking at the American Institute for Economic Research Monetary Conference, Waller expressed that recent inflation data supports a downward trend towards the Fed&#8217;s 2% target. He mentioned that monetary policy remains restrictive despite previous rate cuts.
<a href="https://www.benzinga.com/news/24/12/42282037/federal-reserves-waller-leans-toward-rate-cut-in-december-cites-inflations-downward-path-to-2">Read the full article here.</a>
US Job Market Surges In November
The latest jobs report shows a robust increase in hiring, with nonfarm payrolls rising by 227,000 in November. This marks a significant recovery from October&#8217;s weather-impacted figures. The strong labor market data, coupled with accelerating wage growth, may influence the Federal Reserve&#8217;s decision on interest rate cuts.
<a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42363278/us-economy-adds-227000-jobs-in-november-wage-growth-accelerates">Read the full article here.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/social-media/24/12/42371493/tech-stocks-rise-meta-rallies-as-court-upholds-tiktok-ban-bitcoin-roars-above-101000-whats-driving-markets-friday?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tech Stocks Rise; Meta Rallies As Court Upholds Tiktok Ban; Bitcoin Roars Above $101,000: What&#8217;s Driving Markets Friday?</a></li>
</ul>
Photo courtesy: Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/ananya-gairola" target="_blank" rel="noreferrer noopener">Ananya Gairola</a>

Economics

Media

Jeff Bezos Advocates Growth, Trump's Tariff Threats, And The Fed's Latest Moves: This Week In Economics

The week was buzzing with a whirlwind of news. From Taylor Swift&#8217;s sales soaring despite Trump&#8217;s predictions to AOC challenging Musk&#8217;s DOGE agenda, the news cycle was anything but dull. Here&#8217;s a quick recap of the top stories that made headlines.
Swift&#8217;s Sales Soar Despite Trump&#8217;s Predictions
Contrary to President-elect Donald Trump&#8217;s forecast, Taylor Swift&#8217;s sales have not taken a hit after she endorsed Vice President Kamala Harris. Swift continues to reign supreme in concerts, movies, and streaming lists. Her new &#8220;Eras Tour Book&#8221; is also enjoying immense success. The book offers fans a glimpse into the record-breaking Eras Tour with photos and behind-the-scenes stories.
<a href="https://www.benzinga.com/general/entertainment/24/12/42351922/trump-predicted-taylor-swift-sales-would-drop-target-data-shows-over-800k-sold">Read the full article here.</a>
AOC Challenges Musk&#8217;s DOGE Agenda
Rep. Alexandria Ocasio-Cortez (D-N.Y.) has responded to Elon Musk's call for defunding the American Civil Liberties Union. She also criticized proposed cuts by the Musk-headed Department of Government Efficiency. According to AOC, while the ACLU receives no taxpayer funds, proposals are being made by DOGE to cut funding for essential services, targeting some of the most vulnerable groups in society.
<a href="https://www.benzinga.com/news/24/12/42355184/aoc-challenges-musks-doge-agenda-slams-defund-the-aclu-call-by-trumps-efficiency-czar">Read the full article here.</a>
Trump&#8217;s Personnel Picks: Mixed Reactions
Trump&#8217;s picks for potential nominees for his Cabinet and other White House administration roles have sparked diverse reactions. While some of his choices, like Huckabee and Rubio, have been well-received, others like Kennedy, Oz, and McMahon have faced disapproval.
<a href="https://www.benzinga.com/news/management/24/12/42354639/donald-trumps-personnel-picks-voters-like-huckabee-rubio-picks-disapprove-of-kennedy-oz-mcmahon">Read the full article here.</a>
Trump&#8217;s FBI Pick Kash Patel&#8217;s Wealth Growth
Kash Patel, Trump&#8217;s pick to lead the Federal Bureau of Investigation, has seen his wealth grow through various avenues, including Trump Media &amp; Technology Group. Patel is a loyal Trump supporter and has previously worked for him on the National Security Council.
<a href="https://www.benzinga.com/politics/24/12/42278429/trump-fbi-pick-kash-patels-wealth-has-grown-from-trump-media-board-position-consulting-deal-and-trump-themed-childrens-books">Read the full article here.</a>
Potential Fallout Between Musk and Trump
ARK Invest&#8217;s Cathie Wood has weighed in on the potential repercussions of a possible fallout between President-elect Donald Trump and Elon Musk on Musk's companies, Tesla Inc. and SpaceX. Wood acknowledged the strong personalities of both individuals and the potential risks associated with such a dynamic.
<a href="https://www.benzinga.com/24/12/42260398/how-a-potential-fallout-between-elon-musk-and-trump-could-impact-tesla-and-spacex-cathie-wood-weighs-in">Read the full article here.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/12/42351859/trumps-dea-drama-he-didnt-quit-i-fired-him-a-tale-of-pastors-pandemic-and-hurt-feelings?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump&#8217;s DEA Drama: He Didn&#8217;t Quit, I Fired Him — A Tale Of Pastors, Pandemic And Hurt Feelings</a></li>
</ul>
Photo courtesy: Wikimedia
 This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/anan-ashraf" target="_blank" rel="noopener">Anan Ashraf.</a>

Taylor Swift Defies Trump's Predictions, AOC Challenges Musk's DOGE Agenda, And More: This Week In Politics

Regeneron Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) today announced positive updated Phase 3 data of an exploratory cohort from the ACCESS-1 trial investigating its first-in-class pozelimab and cemdisiran (poze-cemdi) combination treatment against ravulizumab, a standard-of-care complement factor 5 (C5) inhibitor, in patients with paroxysmal nocturnal hemoglobinuria (PNH). Results were shared during an oral session at the American Society of Hematology (ASH) 2024 Annual Meeting and support continued development of poze-cemdi in PNH, including in a separate registrational cohort, as well as in other complement-mediated diseases. Poze-Cemdi is a first-in-class combination of an antibody and an siRNA targeting C5: pozelimab is a fully human monoclonal antibody designed to block the activity of C5, while cemdisiran is an investigational siRNA therapeutic that reduces circulating levels of C5.
Head-to-head exploratory cohort of a Phase 3 trial showed first-in-class poze-cemdi combination treatment helped patients achieve and maintain greater disease control, as measured by lactate dehydrogenase (LDH) levels, compared to standard-of-care ravulizumab
Five patients receiving ravulizumab did not achieve meaningful LDH control compared to one patient receiving poze-cemdi; after switching to the combination, four of the five previously treated with ravulizumab achieved LDH control
A separate registrational cohort is ongoing, investigating poze-cemdi against eculizumab

REGN

- Regeneron Announced Novel Combination Of Pozelimab And Cemdisiran Achieved Greater Control Of Intravascular Hemolysis In Patients With Paroxysmal Nocturnal Hemoglobinuria Vs Ravulizumab

<a href="https://www.globenewswire.com/Tracker?data=XEGcRXK7EisdfyqpSAHjBmx7wFKv7TZrvuA2SkGFbRMzqZ4HpDAgG4Jc2APS5_FkXpodqvA5yeWBOdGeFSuiWA==">Genmab A/S</a>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMAB#NASDAQ">GMAB</a>) today announced new results from the Phase 1b/2 EPCORE&#xAE; NHL-2 trial evaluating fixed-duration epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, plus lenalidomide + rituximab (R2) in adult patients with relapsed or refractory (R/R) follicular lymphoma (FL). The results demonstrated an overall response rate (ORR) of 96 percent and a complete response (CR) rate of 87 percent among 111 patients after a median follow-up of two years. Additionally, the study showed an estimated 21-month progression-free survival (PFS) rate of 80 percent and a two-year overall survival (OS) rate of 90 percent. The data (Abstract #342) were shared today during an oral presentation at the 66th Annual Meeting and Exposition of the American Society of Hematology (ASH).
&nbsp;
<ul>
<li>Results show 96 percent overall response rate (ORR), 87 percent complete response (CR), and 80 percent 21-month progression-free survival (PFS) in patients with relapsed or refractory (R/R) follicular lymphoma (FL) following treatment with epcoritamab plus lenalidomide + rituximab (R2)</li>
<li>Long-term follow-up results demonstrated strong and durable efficacy, with an estimated two-year overall survival (OS) rate of 90 percent</li>
<li>Results follow recent breakthrough therapy designation (BTD) granted by U.S. Food and Drug Administration (FDA) and support ongoing Phase 3EPCORE&#xAE; FL-1 trial evaluating epcoritamab + R2 in patients with R/R FL</li>
</ul>
&nbsp;
&nbsp;

GMAB

Genmab Announced Investigational Epcoritamab Combination Therapy Demonstrates High Response Rates In Clinical Trial Of Patients With Relapsed Or Refractory Follicular Lymphoma At ASH Meeting; Results Show 96% Overall Response Rate

What if your next burger didn't come from a drive-thru or grill but a vending machine? That's the idea behind RoboBurger, the Jersey City startup hoping to reshape fast food with machines that whip up fresh, customizable burgers in under four minutes.&nbsp;
Cofounders Dan Braido, Audley Wilson, and Andy Siegel recently presented their ambitious pitch on ABC's Shark Tank. They aimed for $1.5 million in funding for just 5% of their company. A roller coaster of skepticism, surprises, and a deal followed.
Don't Miss:
<ul>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Last Chance to get 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>
The pitch didn't start on a high note. Investor <a href="https://www.benzinga.com/personal-finance/24/09/40714364/survive-anything-kevin-oleary-claims-you-need-5-million-in-savings-heres-how-you-can-reach-that-">Kevin O'Leary</a> immediately labeled the presentation "chaotic" and demanded clarity on RoboBurger's profitability. "How do I make money? All the rest doesn't matter," he said.&nbsp;
Undeterred, the team demonstrated their $3,000-per-month vending machine, which turned out a "rethermalized" burger – a term that sparked some laughs. Mark Cuban joked it was "a fancy word for ‘reheated,'" though Braido clarified the patties are grilled in the machine, creating a crust while locking in the juices.
The Sharks agreed the burgers were tasty, but eyebrows shot up when the founders revealed a $30 million valuation.&nbsp;
See Also: If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?
RoboBurger sold over 12,000 burgers during an 18-month beta test, with prices ranging from $5.99 to $6.99 and projected annual revenue of $1.4 million. However, with a $700,000 expected loss for the year, the request for $1.5 million seemed like a gamble.
Another point of contention was the financial model. RoboBurger leases machines for $3,000 per month or sells them outright, leaving buyers responsible for stocking. Mark Cuban warned that vending machines are costly to produce and maintain, calling them "hard capital assets" in an industry where technology quickly becomes outdated.&nbsp;
He suggested RoboBurger pivot to licensing its technology. Michael Rubin, Fanatics CEO and guest Shark, echoed the concerns. "How many businesses can realistically afford $3,000 a month plus food costs?" he asked. Still, Rubin saw potential, calling it a "big idea" with the possibility of scaling into a multibillion-dollar <a href="https://www.benzinga.com/startups/24/10/41191588/selling-a-business-for-3-7-billion-was-a-mistake-for-46-year-old-he-recounts-it-as-his-saddest-day-o">business</a>.
Trending: It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
Instead of an equity investment, Rubin proposed a $1.5 million loan with market-rate interest and a 10% equity stake. "This is a very high-risk project with a low probability of success," he said.&nbsp;
Barbara Corcoran criticized the offer as "greedy," but O'Leary warmed to it, calling it a "very Mr. Wonderful structure." Ultimately, O'Leary and Rubin agreed to split the deal, reducing their equity stake to 9% during negotiations.
As RoboBurger secured its $1.5 million, it joined a growing movement toward automation in food service. According to Allied Market Research, the global food vending machine market was valued at $18.3 billion in 2022 and is expected to grow 7.5% annually through 2032.&nbsp;
With consumer demand for convenience at an all-time high – Statista reports the U.S. quick-service restaurant (QSR) sector has grown consistently since 2004, reaching over $349 billion in consumer spending in 2023 – RoboBurger's timing could be just right.
Read Next:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest TODAY for just $0.26/share with a $1000 minimum.</a></li>
<li>This Jeff Bezos-backed startup will allow you to <a href="https://www.benzinga.com/money/bezos-landlord-100-dollars">become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</a></li>
</ul>

Startups

'Rethermalized' Burgers And A $30M Dream: RoboBurger Lands $1.5M Shark Deal After Selling 12,000 Burgers In Beta

<a href="https://www.benzinga.com/topic/donald-trump" target="_blank" rel="noreferrer noopener">Donald Trump</a> voters, along with the broader electorate, expressed overwhelming confidence in the 2024 election process, a striking contrast to the <a href="https://www.benzinga.com/markets/equities/24/04/38476449/voters-reveal-whether-they-feel-donald-trump-is-receiving-fair-treatment-in-court-in-latest-poll">skepticism that marked the 2020 presidential race</a>.
With 88% of voters saying the 2024 elections were run well, up from just 59% in 2020, there&#8217;s a clear shift in perception — especially among Trump supporters, according to a Pew Research Center <a href="https://www.pewresearch.org/politics/2024/12/04/voters-broadly-positive-about-how-elections-were-conducted-in-sharp-contrast-to-2020/">poll</a>.
In the wake of Trump&#8217;s win, 93% of Trump voters believe the elections were &#8220;administered&#8221; well, a dramatic increase from only 21% who felt the same four years ago. This change in attitude highlights how the election&#8217;s outcome has reshaped their views on election integrity.
This newfound confidence is not limited to overall perceptions of election administration but extends to specific aspects of the voting process, including the accuracy of vote counts.
Trump voters, once highly skeptical, are now expressing substantial confidence in both in-person and mail-in vote counts.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/entertainment/24/12/42377867/most-visited-wikipedia-pages-in-2024-trump-harris-musk-swift-politics-and-netflix-dominate-list" rel="noreferrer noopener">Most Visited Wikipedia Pages In 2024: Trump, Harris, Musk, Swift, Politics And Netflix Dominate List</a>
Today, 94% of Trump voters trust in-person ballots were counted correctly, a 30-point jump from 2020, Pew Research finds in the survey. Confidence in absentee ballots has also soared among Trump voters, from 19% in 2020 to 72% in 2024.
While Biden voters remain overwhelmingly confident in the accuracy of both voting methods, with 95% expressing trust in absentee ballot counts in 2020, Harris voters are slightly less confident in the 2024 election. However, 84% of Harris voters still believe elections were well-run, a strong showing that reflects broader approval of the election process.
This dramatic reversal in Trump voters&#8217; views marks a sharp departure from the contentious atmosphere surrounding the 2020 election, showing how the outcome of an election can dramatically shift perceptions of its fairness and execution.
For this analysis, Pew Research surveyed 9,609 U.S. adults, including 8,072 U.S. citizens who reported having voted in the November election. The survey was conducted Nov. 12-17, 2024.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42378030/benzinga-bulls-and-bears-tesla-gamestop-nvidia-bitcoin-and-dogecoin-analyst-flags-1-30-1-50-as-key-target" target="_blank" rel="noreferrer noopener">Benzinga Bulls And Bears: Tesla, GameStop, Nvidia, Bitcoin, And Dogecoin Analyst Flags $1.30-$1.50 As Key Target</a></li>
</ul>

Equities

General

Trump Voters' Trust in Election Process Soars In Sharp Reversal To Post-2020 Feelings

Incyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INCY#NASDAQ">INCY</a>) today announced results from the Phase 3 POD1UM-304 trial of retifanlimab (Zynyz&#xAE;), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with platinum-based chemotherapy for the treatment of adults with previously untreated non-squamous and squamous metastatic non-small cell lung cancer (NSCLC) not harboring a driver mutation. These data were featured today in a mini oral presentation at the European Society for Medical Oncology (ESMO) Asia Congress 2024, held in Singapore and virtually.
&nbsp;
— Phase 3 POD1UM-304 trial met primary endpoint of overall survival (OS) and all secondary endpoints in patients with previously untreated metastatic non-small cell lung cancer (NSCLC)
— Data presented at the European Society for Medical Oncology (ESMO) Asia Congress 2024 support the planned 2025 filing of a supplemental Biologics License Application (sBLA) in the U.S. for retifanlimab in NSCLC

INCY

Incyte Announced Results From Phase 3 Trial Evaluating Retifanlimab In Combination With Platinum-based Chemotherapy In Patients With Non-small Cell Lung Cancer At ESMO Congress; Said Phase 3 POD1UM-304  Trial Met Primary Endpoint Of Overall Survival And All Secondary Endpoints In Patients With Previously Untreated Metastatic NSCLC

Amgen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) today announced&nbsp;new data demonstrating that adding BLINCYTO&#xAE; (blinatumomab) to chemotherapy significantly improves disease-free survival (DFS) in newly diagnosed pediatric patients with National Cancer Institute (NCI) standard risk (SR) B-cell acute lymphoblastic leukemia (B-ALL) of average or higher risk of relapse. The data are from a Phase 3 study (AALL1731) conducted by the Children's Oncology Group. The results were simultaneously <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4319894-1&amp;h=1897591024&amp;u=http%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2411680&amp;a=published">published</a>&nbsp;in the New England Journal of Medicine and will be presented during the plenary session on Sunday, Dec. 8, at 2 p.m. PT at the 66th American Society of Hematology (ASH) Annual Meeting &amp; Exposition in San Diego.
Based on the results of the first pre-specified interim analysis for efficacy, the study met its primary endpoint of DFS and study randomization was terminated early based on the recommendation from the data and safety monitoring committee due to the benefit observed in the BLINCYTO arm compared to the chemotherapy-only arm. Overall, the 3-year DFS was 96.0% for patients treated with chemotherapy plus BLINCYTO compared to 87.9% for those treated with only chemotherapy. The hazard ratio (HR) was 0.39 [95% confidence interval (CI) 0.24-0.64], indicating a 61% reduction in the risk of disease relapse, secondary malignant neoplasm or remission death with BLINCYTO. At 3 years, more patients remained alive and cancer free when treated with BLINCYTO plus chemotherapy compared to chemotherapy alone.

AMGN

Amgen Announced Blincyto Added To Chemotherapy Significantly Improves Survival In Newly Diagnosed Pediatric Patients With B-cell Precursor Acute Lymphoblastic Leukemia At ASH; Said Phase 3 Study Results Demonstrated Three Year, Disease-Free Survival of 96%

<a href="https://www.globenewswire.com/Tracker?data=iLZ9x69dnGVH2dDnn_bqKdcRxuqSk8c9oR7gIU98LWWR7EKFfy8SYnFEVh3zx6Q_3ZtiiGoWRO5HH5TVXoK6RKufAiNiO3mNqfmZfC89hSY=">Beam Therapeutics Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>), a biotechnology company developing precision genetic medicines through base editing, today announced new safety and efficacy data from its BEACON Phase 1/2 clinical trial of BEAM-101 in patients with sickle cell disease (SCD) with severe vaso-occlusive crises (VOCs). The data were featured today in the press program for the 66th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego and will be presented in an oral session on Sunday, Dec. 8, 2024, at 10 a.m. PT.
All Seven Patients Treated with BEAM-101 Achieved Hemoglobin F (HbF) Induction of &gt;60%, Hemoglobin S (HbS) Reduction to &lt;40%, and Resolution of Anemia Post-BEAM-101 Treatment
Initial Safety Profile Consistent with Busulfan Conditioning and Autologous Hematopoietic Stem Cell Transplantation
All Seven Patients Dosed Achieved Target Cell Dose with One or Two Mobilization Cycles and Experienced Rapid Neutrophil and Platelet Engraftment
Markers of Hemolysis Normalized or Improved in All Patients

BEAM

Beam Therapeutics Announced New Data from BEACON Phase 1/2 Clinical Trial Of BEAM-101 In Sickle Cell Disease at ASH Meeting; Said All Seven Patients Treated With BEAM-101 Achieved Hemoglobin F (HbF) Induction Of >60%, Hemoglobin S (HbS) Reduction To <40%, And Resolution Of Anemia Post-BEAM-101 Treatment

Positive results from the pivotal LUNA 3 phase 3 study of rilzabrutinib in adults with persistent or chronic immune thrombocytopenia (ITP), a rare immune-mediated disease, reinforce the efficacy and safety of rilzabrutinib, an oral, reversible, covalent Bruton's tyrosine kinase (BTK) inhibitor, and further support its potential as a first-in-class treatment for ITP. Platelet response was achieved in 65% (n=86) of patients receiving rilzabrutinib compared to 33% (n=23) of patients on placebo. The primary endpoint was met, with rilzabrutinib demonstrating durable platelet response in 23% of ITP adult patients compared to 0% on the placebo arm (p&lt;0.0001), as well as key secondary endpoints including reduced bleeding, number of weeks with platelet response, the need for rescue therapy use, and improved physical fatigue and quality of life measures.

Sanofi Announced Rilzabrutinib Demonstrated Significant Patient Benefit In First Positive Phase 3 Study Of BTK Inhibitor In ITP At ASH; Said  Phase 3 Data Show Rapid And Durable Platelet Response, Reduced Bleeding And Need For Rescue Response

Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YMAB#NASDAQ">YMAB</a>), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the treatment of cancer, today announced the presentation of CD38-SADA in Non-Hodgkin Lymphoma (NHL) preclinical data and trial in progress posters at the 66th American Society of Hematology (ASH) Annual Meeting &amp; Exposition being held on December 7 –10, 2024, in San Diego, California.
A poster titled "CD38-SADA, a Self-Assembling and Dis-Assembling Bispecific Fusion Protein for Two-Step Pretargeted Radioimmunotherapy of Non-Hodgkin Lymphoma" characterizes the selective binding of CD38-SADA to DOTA-chelated lanthanide metals and high-avidity binding to CD38, a tumor specific antigen overexpressed across a range of lymphoma cells. Data from this poster demonstrate anti-tumor efficacy of CD38-SADA when used with Lutetium 177 (Lu177)-DOTA in a two-step approach to pre-targeted radioimmunotherapy ("PRIT"). Tumor responses in a xenograft mouse model were rapid and dose-dependent, further supporting the clinical development of CD38-SADA PRIT in patients with CD38-positive lymphoid malignancies.
"This preclinical analysis provides important insights into the unique pharmacology of CD38-SADA and its therapeutic potential for NHL," said&nbsp;Brian H. Santich, Ph.D., the lead author and co-inventor of the SADA PRIT technology platform. "The anti-tumor efficacy positively correlated with increasing doses of Lu177-DOTA and CD38-SADA, which informed the study design and initial dosing regimen of our Trial 1201 in patients with NHL."

YMAB

Y-mAbs Presents SADA Platform Preclinical Data And Trial In Progress Posters At ASH Meeting; Said Anti-tumor Efficacy Positively Correlated With Increasing Doses Of  Lu177-DOTA And CD38-SADA

bluebird bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLUE#NASDAQ">BLUE</a>) today announced updated data from patients with beta-thalassemia who require regular blood transfusions treated with betibeglogene autotemcel (beti-cel, approved commercially as ZYNTEGLO&#x2122;) in clinical studies. The data was presented today at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition.
Long-Term Follow-Up Data Continue to Support Beti-Cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independence and Normal or Near-Normal Adult Hb Levels
Treatment effects sustained through long-term follow-up of beyond 10 years in the earliest treated patients (n=2); 81% of participants have &gt;5 years of follow-up

BLUE

bluebird bio Announced Long-Term Follow-Up Data Continue To Support Beti-Cel As Potentially Curative Gene Therapy For β-Thalassemia Patients Who Require Regular Transfusions Through Achievement Of Durable Transfusion Independence And Normal Or Near-Normal Adult Hb Levels At ASH Meeting

Comments

Williams Rowland Acquisition Corp arrants (11/12/2026)

Williams Rowland Acquisition Corp arrants (11/12/2026) (WRACW) Forecast

Williams Rowland Acquisition Corp arrants (11/12/2026) (OTC:WRACW) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga